A new risk model uses objective clinical data to predict cure or relapse in Hodgkin lymphoma, with future plans to guide treatment and survivorship care.

The agreement will enable the use of Modella AI’s latest models, with rich feature extraction from different types of data, ...

Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent decades. Integrating AI should allow developers to adopt a more data ...

By Enes Hosgor and Smit Patel. Jan. 3, 2025. Hosgor is the founder and CEO of Gesund.ai. Patel is the director of digital health and AI at the Digital Medicine Society (DiMe).

A new AI algorithm is nearly twice as accurate as physicians at forecasting a sudden cardiac arrest in people with ...

Researchers develop an AI model that uses ECG data to predict the risk for adverse vascular events in patients with migraine.

Lakshmi Priya Darshini Pulavarthi blends scientific expertise with data management to drive clinical trial success across oncology, hematology, and cardiovascular therapeutic areas.

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...